Previous 10 |
Acura Pharmaceuticals ( OTCPK:ACUR ): Q1 GAAP EPS of -$0.04. More news on: Acura Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
PALATINE, Ill., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and product candidates intended to mitigate the risk of outcomes associated with product misuse announ...
Acura Pharmaceuticals ( OTCPK:ACUR ): Q4 GAAP EPS of $0.00. More news on: Acura Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
PALATINE, Ill., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and product candidates intended to mitigate the risk of outcomes associated with product misuse annou...
PALATINE, Ill., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTC Pink: ACUR), today announced that it has engaged Catalent Pharma Solutions, LLC (“Catalent”) to initiate manufacturing scale-up of LTX-03 (Hydrocodone Bitartrate and Acetaminophen) Tablets to u...
Agreement Provides For Completion of Development and Commercialization Transaction Valued at up to $21.3 Million, not including Royalties PALATINE, Ill., July 02, 2019 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTC Pink: ACUR) today announced a License, Development and Commerci...
NEW YORK , June 5, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lists of downgrades from its respective OTCQX® and OTCQB® markets and Caveat Emptor Desig...
A study just published in JAMA Open Network conducted by researchers at Brown University found a strong link between the amount spent on marketing by opioid manufacturers and the number of prescriptions written by doctors, leading to a rise in opioid overdose deaths. More news on: Endo...
News, Short Squeeze, Breakout and More Instantly...
Acura Pharmaceuticals Inc. Company Name:
ACUR Stock Symbol:
OTCMKTS Market:
Acura Pharmaceuticals Inc. Website:
Acura Pharmaceuticals Inc. (ACUR) is expected to report for Q3 2022
PALATINE, Ill., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended to address safe use of medications, announced today financial res...
PALATINE, Ill., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended to address safe use of medications, announced today financial res...